Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 42,332 | 45,937 | 43,994 | 28,118 | 27,687 |
| Marketable Securities | 113,810 | 110,251 | 39,303 | 42,861 | 36,605 |
| Receivables | 23,033 | 24,792 | 18,663 | 35,842 | 31,609 |
| Inventories | 46,481 | 48,620 | 54,746 | 49,773 | 47,106 |
| Income taxes - deferred | 6 | N/A | N/A | N/A | N/A |
| Other current assets | 3,644 | 2,981 | 2,954 | 4,695 | 1,440 |
| TOTAL | $235,791 | $240,037 | $165,324 | $164,394 | $147,268 |
| Non-Current Assets | |||||
| PPE Net | 57,684 | 57,883 | 57,421 | 808 | 780 |
| Investments And Advances | 2,063 | 1,873 | 2,016 | 18,295 | 19,622 |
| Intangibles | 14,364 | 9,320 | 9,157 | 2,971 | 4,277 |
| Other Non-Current Assets | 306 | 331 | 324 | 347 | 368 |
| TOTAL | $74,417 | $69,407 | $68,918 | $22,421 | $25,047 |
| Total Assets | $310,208 | $309,444 | $234,242 | $186,815 | $172,315 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 10,333 | 4,880 | 4,855 | N/A | N/A |
| Accounts payable and accrued liabilities | 24,937 | 23,134 | 24,517 | 22,397 | 21,813 |
| Accrued Expenses | 21,744 | 18,033 | 15,676 | 14,920 | 11,615 |
| Other current liabilities | 3,129 | 2,480 | 3,406 | 5,566 | 7,026 |
| TOTAL | $63,524 | $54,339 | $50,896 | $42,883 | $40,454 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 14,314 | 14,240 | N/A | N/A |
| Deferred Revenues | 3,381 | 5,812 | 2,442 | N/A | N/A |
| Other Non-Current Liabilities | 2,323 | 1,619 | 1,624 | 6 | 6 |
| TOTAL | $10,658 | $24,166 | $27,303 | $6 | $6 |
| Total Liabilities | $74,182 | $78,505 | $78,199 | $42,889 | $40,460 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,840 | 31,772 | 28,199 | 28,142 | 28,137 |
| Common Shares | 318 | 318 | 282 | 281 | 281 |
| Retained earnings | -114,057 | -117,617 | -120,443 | -133,813 | -143,651 |
| Other shareholders' equity | 487 | 111 | -80 | 2,472 | 2,500 |
| TOTAL | $236,026 | $230,939 | $156,043 | $143,926 | $131,855 |
| Total Liabilities And Equity | $310,208 | $309,444 | $234,242 | $186,815 | $172,315 |